Vanda Pharmaceuticals Inc [NASDAQ: VNDA] Sees Decrease in Stock Value
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $25863.0 on Nov
Vanda Pharmaceuticals Inc’s filing revealed that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $25863.0 on Nov 14
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $25863.0 on Nov
In a filing, Vanda Pharmaceuticals Inc revealed its SVP, CFO & Treasurer Moran Kevin Patrick unloaded Company’s shares for reported
Vanda Pharmaceuticals Inc’s recently made public that its SVP, CFO & Treasurer Moran Kevin Patrick unloaded Company’s shares for reported
Vanda Pharmaceuticals Inc’s recently made public that its SVP, CFO & Treasurer Moran Kevin Patrick unloaded Company’s shares for reported
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) does about 670.95K shares in volume on a normal day but saw 493956 shares change hands
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.